XML 29 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands
Total
Share Repurchase Program [Member]
Common Stock [Member]
Additional Paid-in-Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income [Member]
Treasury Stock [Member]
Treasury Stock [Member]
Share Repurchase Program [Member]
Noncontrolling Interest
Balance (in shares) at Sep. 29, 2018     289,900       19,812    
Balance at Sep. 29, 2018 $ 2,428,800,000   $ 2,900,000 $ 5,671,300,000 $ (2,494,000,000) $ (25,500,000) $ (725,900,000)   $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Accounting standard transition adjustment - ASC 606 6,400,000       6,400,000        
Accounting standard transition adjustment - ASU 2016-16 2,500,000       2,500,000        
Exercise of stock options (in shares)     1,304            
Stock Issued During Period, Value, Stock Options Exercised 32,800,000     32,800,000          
Vesting of restricted stock units, net of shares withheld for employee taxes (in shares)     645            
Restricted Stock, Value, Shares Issued Net of Tax Withholdings (12,800,000)     (12,800,000)          
Common stock issued under the employee stock purchase plan (in shares)     474            
Stock Issued During Period, Value, Employee Stock Purchase Plan 16,500,000     16,500,000          
APIC, Share-based Payment Arrangement, Increase for Cost Recognition 62,000,000.0     62,000,000.0          
Repurchase of common stock (in shares)             4,826    
Treasury Stock, Value, Acquired, Par Value Method (200,100,000)           $ (200,100,000)    
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent (14,800,000)         (14,800,000)      
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent (600,000)         (600,000)      
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax (8,000,000.0)         (8,000,000.0)      
Unrealized gain on interest rate swap 3,500,000         3,500,000      
Net income (loss) attributable to Hologic (203,600,000)       (203,600,000)        
Balance (in shares) at Sep. 28, 2019     292,323       24,638    
Balance at Sep. 28, 2019 2,115,700,000   $ 2,900,000 5,769,800,000 (2,688,700,000) (42,300,000) $ (926,000,000.0)   0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax           3,100,000      
Exercise of stock options (in shares)     1,761            
Stock Issued During Period, Value, Stock Options Exercised 48,300,000     48,300,000          
Vesting of restricted stock units, net of shares withheld for employee taxes (in shares)     611            
Restricted Stock, Value, Shares Issued Net of Tax Withholdings (14,200,000)     (14,200,000)          
Common stock issued under the employee stock purchase plan (in shares)     412            
Stock Issued During Period, Value, Employee Stock Purchase Plan 17,600,000     17,600,000          
APIC, Share-based Payment Arrangement, Increase for Cost Recognition 83,300,000     83,300,000          
Repurchase of common stock (in shares)             9,064 3,907  
Treasury Stock, Value, Acquired, Par Value Method (448,600,000) $ (205,000,000.0)         $ (448,600,000) $ (205,000,000.0)  
Unrealized gain (loss) on interest rate cap, net of taxes (500,000)         (500,000)      
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent 18,500,000         18,500,000      
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent (100,000)         (100,000)      
Unrealized gain on interest rate swap (27,600,000)         (27,600,000)      
Net income (loss) attributable to Hologic 1,110,500,000       1,115,200,000       (4,700,000)
Noncontrolling Interest, Increase from Business Combination 8,600,000               8,600,000
Accounting standard transition adjustment - ASC 842 | Accounting Standards Update 2018-01 [Member]         300,000        
Balance (in shares) at Sep. 26, 2020     295,107       37,609    
Balance at Sep. 26, 2020 $ 2,707,300,000   $ 2,900,000 5,904,800,000 (1,573,200,000) (49,700,000) $ (1,579,600,000)   2,100,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax           2,300,000      
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests                 1,800,000
Exercise of stock options (in shares) 800   857            
Stock Issued During Period, Value, Stock Options Exercised $ 32,900,000     32,900,000          
Vesting of restricted stock units, net of shares withheld for employee taxes (in shares)     980            
Restricted Stock, Value, Shares Issued Net of Tax Withholdings (47,500,000)     (47,600,000)          
Common stock issued under the employee stock purchase plan (in shares)     362            
Stock Issued During Period, Value, Employee Stock Purchase Plan 18,900,000     18,900,000          
APIC, Share-based Payment Arrangement, Increase for Cost Recognition 65,000,000.0     65,000,000.0          
Repurchase of common stock (in shares)             6,044    
Treasury Stock, Value, Acquired, Par Value Method (409,800,000)           $ (409,800,000)    
Unrealized gain (loss) on interest rate cap, net of taxes 400,000         400,000      
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent (20,200,000)         (20,200,000)      
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 500,000         500,000      
Unrealized gain on interest rate swap 9,400,000         9,400,000      
Net income (loss) attributable to Hologic 1,869,700,000       1,871,500,000       (1,800,000)
Balance (in shares) at Sep. 25, 2021     297,306       43,653    
Balance at Sep. 25, 2021 4,218,600,000   $ 3,000,000.0 5,965,800,000 $ 298,300,000 (59,100,000) $ (1,989,400,000)   0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Purchase of non-controlling interest reclassified to APIC       $ (8,200,000)          
Change in par value 100,000                
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax           $ 500,000      
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests $ 8,500,000               $ (300,000)